Cardiovascular research in Australia

Sheila A Doggrell1

  • 1Doggrell Biomedical Communication, Lynfield, Auckland, New Zealand. s_doggrell@yahoo.com

Drug News & Perspectives
|December 12, 2003
PubMed

The Baker Heart Research Institute (BHRI), one of Australia's finest research facilities, played host to the 27th annual Australasian Section of the International Society for Heart Research meeting, New Science at the Heart of New Therapies, August 7-9, 2003. This report discusses the keynote lectures (Prophylactic Effects of Statins on Ischaemic Heart Disease, Diet and Wine as Cardioprotection, Artificial Heart Technology and Therapeutics) and the symposia presented at the meeting. The topics for the symposia were vascular regulatory mechanisms, adaptation and regulation of myocardial metabolism, signaling and mechanisms in hypertrophy/fibrosis, gender and cardiovascular disease and the dilemma of diabetes. The high standard of the presented material clearly demonstrates the strength that Australia in general and the BHRI in particular have in cardiovascular research.

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Psychoneuroimmunology: Cardiovascular Disease01:27

Psychoneuroimmunology: Cardiovascular Disease

Psychoneuroimmunology (PNI) is a multidisciplinary field that examines how psychological factors, particularly stress, interact with the immune system and impact physical health. Research in PNI has shown that chronic or traumatic stress can disrupt both the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system. These disruptions contribute to serious health conditions, including cardiovascular diseases.
A key area of focus in PNI is the relationship between stress and coronary...